GLG Inc’s Boston Scientific BSX Stock Holding History

GLG Inc’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$1.68M	Hold	140,041	–	–	0.04%	394
2013 Q3	$1.64M	Hold	140,041	–	–	0.03%	465
2013 Q2	$1.3M	Buy	+140,041	New	+$1.19M	0.03%	398

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

GLG Inc's BSX Position: Q4 2013 in Review

GLG Inc held its Boston Scientific (BSX) position steady in Q4 2013 at 140,041 shares worth $1.68M. The position accounts for 0.04% of the portfolio, ranked #394.

GLG Inc first reported a position in BSX in Q2 2013 and has held it in 3 quarters since. 450 funds tracked by Wall St. Rank hold BSX as of Q4 2013.

GLG Inc held 140,041 shares of Boston Scientific worth $1.68M as of Q4 2013.
GLG Inc left its Boston Scientific share count unchanged in Q4 2013.
Boston Scientific made up 0.04% of GLG Inc's portfolio in Q4 2013, its #394 holding.
GLG Inc first reported a position in Boston Scientific in Q2 2013 and has held it in 3 quarters since.
450 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2013.

Based on GLG Inc's 13F filing for Q4 2013, filed 14 Feb 2014.